Guangdong taienkang Pharmaceutical Co., Ltd
Initial public offering and listing on GEM
Announcement on online subscription and winning rate
Sponsor (lead underwriter): Guotai Junan Securities Co.Ltd(601211)
hot tip
The application of Guangdong taienkang Pharmaceutical Co., Ltd. (hereinafter referred to as "the issuer" or "the company") for the initial public offering of 59.1 million RMB common shares (A shares) (hereinafter referred to as "this offering") has been examined and approved by the venture board listing committee of Shenzhen Stock Exchange (hereinafter referred to as "Shenzhen Stock Exchange"), And has been registered by the China Securities Regulatory Commission (hereinafter referred to as the "CSRC") (zjxk [2022] No. 203).
The issuer and the sponsor (lead underwriter) Guotai Junan Securities Co.Ltd(601211) (hereinafter referred to as " Guotai Junan Securities Co.Ltd(601211) " or "sponsor (lead underwriter)") negotiated and determined that the number of shares to be issued this time is 59.1 million, and the issue price is 19.93 yuan / share.
The issuing price of this offering does not exceed the median and weighted average of the offline investors' quotation after excluding the highest quotation, as well as the Securities Investment Fund (hereinafter referred to as "public fund"), the National Social Security Fund (hereinafter referred to as "social security fund"), the basic old-age insurance fund (hereinafter referred to as "pension") established through public offering after excluding the highest quotation The enterprise annuity fund (hereinafter referred to as "enterprise annuity fund") established in accordance with the measures for the administration of enterprise annuity fund and the insurance fund (hereinafter referred to as "insurance fund") in accordance with the measures for the administration of the use of insurance funds, whichever is lower. According to item (IV) of Article 39 of the detailed rules for the implementation of the issuance and underwriting business of initial public offering on the gem of Shenzhen Stock Exchange (revised in 2021) (SZS [2021] No. 919), the relevant subsidiaries of the sponsor need not participate in this strategic placement.
According to the final price, the final strategic placement quantity of the special asset management plan for the senior management and core employees of the issuer is 5435022 shares.
The final number of strategic placement shares issued this time is 5435022 million, accounting for 9.20% of the number issued this time. The difference between the initial number of strategic placement shares and the final number of strategic placement shares is 3429978 million shares, which will be transferred back to offline issuance.
This issuance is finally carried out by a combination of directional placement to strategic investors, offline inquiry placement to qualified investors (hereinafter referred to as "offline issuance") and online pricing issuance to social public investors holding non restricted A-share shares or non restricted depositary receipts market value in Shenzhen market (hereinafter referred to as "online issuance").
After the callback of strategic placement and before the launch of online and offline callback mechanism, the initial number of offline issuance was 38594478 shares, accounting for 71.92% of the number issued after deducting the final number of strategic placement; The initial number of shares issued online was 150705 million, accounting for 28.08% of the number issued after deducting the final strategic placement. The total number of offline and online issuance after the callback of strategic placement is 53664978 million shares, and the final number of online and offline issuance will be determined according to the callback.
On March 18, 2022 (t day), the issuer initially issued 150705 million shares of "taienkang" by using the online pricing of the trading system of Shenzhen Stock Exchange.
Investors are kindly requested to focus on the issuance process, payment and other links of this issuance, and timely fulfill the payment obligation on March 22, 2022 (T + 2).
1. Offline investors shall, according to the announcement on the results of initial public offering of shares by Guangdong taienkang Pharmaceutical Co., Ltd. and initial offline placement of shares listed on the gem, timely and fully pay the subscription funds for new shares according to the final issuance price and initial placement quantity before 16:00 on March 22 (T + 2) 2022. If the same placing object receives multiple new shares on the same day, it is necessary to pay for each new share in full and fill in the remarks in accordance with the specifications. If the placing object has insufficient funds for a single new share, all the new shares allocated to the placing object on that day will be invalid, and the resulting consequences shall be borne by the investors themselves.
After the online investors win the lottery in the subscription of new shares, they shall fulfill the obligation of capital settlement according to the announcement on the results of initial public offering and online lottery of Guangdong taienkang Pharmaceutical Co., Ltd. listed on the gem, so as to ensure that their capital account has sufficient capital for the subscription of new shares by the end of March 22 (T + 2) 2022. The insufficient part shall be deemed to have given up the subscription, and the resulting consequences and relevant legal liabilities shall be borne by the investors themselves. The transfer of investors' funds shall comply with the relevant provisions of the securities company where the investors are located.
The shares abandoned by offline and online investors shall be underwritten by the sponsor (lead underwriter).
2. Among the stocks issued this time, the stocks issued online have no circulation restrictions and limited sales period arrangements, and can be circulated from the date when the stocks issued this time are listed on the Shenzhen Stock Exchange.
The offline issuance part adopts the proportional sales restriction method, and the offline investors shall promise that the sales restriction period of 10% (rounded up) of the number of shares allocated to them is 6 months from the date of the issuer's initial public offering and listing. That is, among the shares allocated to each placing object, 90% of the shares are sold indefinitely and can be circulated from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange; The sales restriction period of 10% of the shares is 6 months, and the sales restriction period starts from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange.
When offline investors participate in the preliminary inquiry and quotation and offline purchase, they do not need to fill in the arrangement of the restricted sale period for the placing objects under their management. Once the quotation is made, it is deemed to accept the arrangement of the online restricted sale period disclosed in this announcement.
In terms of strategic placement, the special asset management plan for senior managers and core employees of the issuer promises that the restricted period of the shares allocated this time is 12 months, which shall be calculated from the date of listing of the shares publicly issued this time on the Shenzhen Stock Exchange. After the expiration of the restricted sale period, the reduction of the allocated shares by strategic investors shall be subject to the relevant provisions of the CSRC and the Shenzhen Stock Exchange on share reduction.
3. When the total number of shares paid and subscribed by offline and online investors is less than 70% of the number of public offerings, the issuer and the sponsor (lead underwriter) will suspend the issuance of new shares and disclose the reasons for the suspension and subsequent arrangements.
4. If the offline investor who provides effective quotation fails to participate in the subscription or the offline investor who obtains the preliminary placement fails to pay the subscription amount in time and in full, it will be deemed as a breach of contract and shall bear the liability for breach of contract. The recommendation institution (lead underwriter) shall report the breach of contract to the China Securities Association for the record. Calculate the number of illegal mergers and placements on the main board of Kechuang and gem. During the period of being included in the restricted list, the placing object shall not participate in the offline inquiry and placement of projects related to science and innovation board, gem, motherboard and other sectors.
If online investors fail to pay in full after winning the lottery for three times in a row within 12 months, they shall not participate in the online subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds within 6 months (calculated as 180 natural days, including the next day) from the next day of the settlement participant's latest declaration of abandonment of subscription.
1、 Online subscription
According to the data provided by Shenzhen Stock Exchange, the sponsor (lead underwriter) has made statistics on the subscription of this online offering. The number of effective subscription accounts of this online pricing offering is 12302673, the number of effective subscription shares is 120377435000, the total number of allotments is 240754870, the starting number of allotments is 000000 Ping An Bank Co.Ltd(000001) , and the ending number is 0 Do-Fluoride New Materials Co.Ltd(002407) 54870.
2、 Implementation of callback mechanism, issuance structure and success rate of online issuance
According to the callback mechanism announced in the announcement of Guangdong taienkang Pharmaceutical Co., Ltd. on initial public offering and listing on the gem, the initial effective online subscription multiple is 798762052 times, higher than
100 times, the issuer and the recommendation institution (lead underwriter) decided to start the callback mechanism, and 20.00% (rounded up to an integral multiple of 500 shares, i.e. 107330000 shares) of the number of shares in this public offering after deducting the final strategic placement will be transferred back from the Internet to the Internet.
After the call back, the final number of shares issued offline was 27861478, accounting for 51.92% of the number of shares issued this time after deducting the final strategic placement; The final number of shares issued online was 25.835 million, accounting for 48.08% of the number issued this time after deducting the final strategic placement. After the call back, the final winning rate of this online pricing issuance is 00214354958%, and the subscription multiple is 466515918 times.
3、 Online lottery
The sponsor (lead underwriter) and the issuer will conduct lottery in Room 202, building 203, Shangbu Industrial Zone, Hongli West Road, Futian District, Shenzhen on the morning of March 21, 2022 (T + 1), and will publish the lottery results in China Securities News, Shanghai Securities News, securities times and securities daily on March 22, 2022 (T + 2).
Issuer: sponsor (lead underwriter) of Guangdong taienkang Pharmaceutical Co., Ltd.: Guotai Junan Securities Co.Ltd(601211) March 21, 2022
(there is no text on this page, which is the seal page of the announcement on the online subscription and winning rate of Guangdong taienkang Pharmaceutical Co., Ltd. for its initial public offering and listing on the GEM)
Guangdong taienkang Pharmaceutical Co., Ltd
(there is no text on this page, which is the seal page of the announcement on the online subscription and winning rate of Guangdong taienkang Pharmaceutical Co., Ltd. for its initial public offering and listing on the GEM)
Guotai Junan Securities Co.Ltd(601211) mm / DD / yyyy
